172 related articles for article (PubMed ID: 19913315)
1. Evaluation of anti-Ostertagia ostertagi antibodies in individual milk samples as decision parameter for selective anthelmintic treatment in dairy cows.
Charlier J; Vercruysse J; Smith J; Vanderstichel R; Stryhn H; Claerebout E; Dohoo I
Prev Vet Med; 2010 Feb; 93(2-3):147-52. PubMed ID: 19913315
[TBL] [Abstract][Full Text] [Related]
2. Predicting milk-production responses after an autumn treatment of pastured dairy herds with eprinomectin.
Charlier J; Duchateau L; Claerebout E; Vercruysse J
Vet Parasitol; 2007 Feb; 143(3-4):322-8. PubMed ID: 16989949
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal study of gastrointestinal parasites in Canadian dairy farms. The value of an indirect Ostertagia ostertagi ELISA as a monitoring tool.
Sanchez J; Dohoo I; Nødtvedt A; Keefe G; Markham F; Leslie K; DesCôteaux L; Campbell J
Vet Parasitol; 2002 Aug; 107(3):209-26. PubMed ID: 12127251
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of gastrointestinal parasites in English dairy farms. Practices and factors associated with first lactation heifer exposure to Ostertagia ostertagi on pasture.
Bellet C; Green MJ; Bradley AJ; Kaler J
J Dairy Sci; 2018 Jan; 101(1):537-546. PubMed ID: 29128225
[TBL] [Abstract][Full Text] [Related]
5. A bulk tank milk survey of Ostertagia ostertagi antibodies in dairy herds in Prince Edward Island and their relationship with herd management factors and milk yield.
Sanchez J; Dohoo I
Can Vet J; 2002 Jun; 43(6):454-9. PubMed ID: 12058571
[TBL] [Abstract][Full Text] [Related]
6. Predicting the effect of anthelmintic treatment on milk production of dairy cattle in Canada using an Ostertagia ostertagi ELISA from individual milk samples.
Vanderstichel R; Dohoo I; Sanchez J; Sithole F; Keefe G; Stryhn H
Prev Vet Med; 2013 Aug; 111(1-2):63-75. PubMed ID: 23647705
[TBL] [Abstract][Full Text] [Related]
7. A survey to determine relationships between bulk tank milk antibodies against Ostertagia ostertagi and milk production parameters.
Charlier J; Claerebout E; Duchateau L; Vercruysse J
Vet Parasitol; 2005 Apr; 129(1-2):67-75. PubMed ID: 15817205
[TBL] [Abstract][Full Text] [Related]
8. The value of bulk milk ELISA Ostertagia antibody titres as indicators of milk production response to anthelmintic treatment in the dry period.
Kloosterman A; Ploeger HW; Pieke EJ; Lam TJ; Verhoeff J
Vet Parasitol; 1996 Sep; 64(3):197-205. PubMed ID: 8888553
[TBL] [Abstract][Full Text] [Related]
9. The use of an indirect Ostertagia ostertagi ELISA to predict milk production response after anthelmintic treatment in confined and semi-confined dairy herds.
Sanchez J; Dohoo I; Leslie K; Keefe G; Markham F; Sithole F
Vet Parasitol; 2005 Jun; 130(1-2):115-24. PubMed ID: 15893078
[TBL] [Abstract][Full Text] [Related]
10. A survey of the exposure to Ostertagia ostertagi in dairy cow herds in Europe through the measurement of antibodies in milk samples from the bulk tank.
Forbes AB; J Vercruysse ; Charlier J
Vet Parasitol; 2008 Oct; 157(1-2):100-7. PubMed ID: 18692964
[TBL] [Abstract][Full Text] [Related]
11. Ostertagia ostertagi antibodies in bulk tank milk from dairy cattle in Italy: A nation-wide survey.
Bosco A; Amadesi A; Morandi N; Pepe P; Maurelli MP; Cringoli G; Rinaldi L
Vet Parasitol Reg Stud Reports; 2018 Aug; 13():166-170. PubMed ID: 31014867
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive indicators associated with the milk yield response after anthelmintic treatment at calving in dairy cows.
Verschave SH; Vercruysse J; Forbes A; Opsomer G; Hostens M; Duchateau L; Charlier J
BMC Vet Res; 2014 Nov; 10():264. PubMed ID: 25394846
[TBL] [Abstract][Full Text] [Related]
13. Relationships between bulk-tank antibodies to Ostertagia ostertagi and herd-management practices and measures of milk production in Nova Scotia dairy herds.
Guitián FJ; Dohoo IR; Markham RJ; Conboy G; Keefe GP
Prev Vet Med; 1999 Oct; 47(1-2):79-89. PubMed ID: 11018736
[TBL] [Abstract][Full Text] [Related]
14. Bulk tank milk prevalence and production losses, spatial analysis, and predictive risk mapping of Ostertagia ostertagi infections in Mexican cattle herds.
Villa-Mancera A; Pastelín-Rojas C; Olivares-Pérez J; Córdova-Izquierdo A; Reynoso-Palomar A
Parasitol Res; 2018 May; 117(5):1613-1620. PubMed ID: 29594346
[TBL] [Abstract][Full Text] [Related]
15. Associations between dairy herd management factors and bulk tank milk antibody levels against Ostertagia ostertagi.
Charlier J; Claerebout E; De Mûelenaere E; Vercruysse J
Vet Parasitol; 2005 Oct; 133(1):91-100. PubMed ID: 15964688
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal survey of anti-Ostertagia ostertagi antibody levels in individual and bulk tank milk in two dairy herds in Normandy.
Charlier J; Camuset P; Claerebout E; Courtay B; Vercruysse J
Res Vet Sci; 2007 Oct; 83(2):194-7. PubMed ID: 17258252
[TBL] [Abstract][Full Text] [Related]
17. A multi-country study to assess the effect of a treatment with moxidectin pour-on during the dry period on milk production in dairy cows.
Geurden T; Bartram DJ; Vanimisetti HB; Fanke J; Camuset P; Devos J; Sawyer A; von Samson-Himmelstjerna G; Demeler J; Charlier J
Vet Parasitol; 2017 Apr; 237():104-109. PubMed ID: 28259556
[TBL] [Abstract][Full Text] [Related]
18. The effect of an experimentally induced acute mastitis on the test results of an Ostertagia ostertagi milk ELISA.
Charlier J; Duchateau L; Vangroenweghe F; Claerebout E; Burvenich C; Vercruysse J
Vet Parasitol; 2006 Mar; 136(2):161-5. PubMed ID: 16300898
[TBL] [Abstract][Full Text] [Related]
19. The effect of repeated, four-weekly eprinomectin treatment on milk production in pasture-based, seasonally-calving dairy cattle.
Mason WA; Pomroy WE; Lawrence KE; Scott I
Vet Parasitol; 2012 Oct; 189(2-4):250-9. PubMed ID: 22664339
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of multi-indicator profiles for targeted-selective treatment against gastrointestinal nematodes at housing in adult dairy cows.
Ravinet N; Lehebel A; Bareille N; Lopez C; Chartier C; Chauvin A; Madouasse A
Vet Parasitol; 2017 Apr; 237():17-29. PubMed ID: 28274492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
